In this photo illustration, boxes of the diabetes drug Ozempic rest on a pharmacy counter on April 17, 2023 in Los Angeles, ...
The FDA just slammed the door on its booming weight-loss drug business--but Hims & Hers has a bold new strategy.
Delhi's new BJP-led administration announced a significant healthcare reform strategy, addressing staffing shortages, ...
Hims & Hers Health, Inc. is a dramatically undervalued company if your holding period can be measured in decades. Read more ...
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, ...
Hims & Hers bought an at-home lab testing company as it branches out into other clinical areas beyond its recent ...
Hims & Hers Health (HIMS) is jumping 15% after the company announced that it had made an acquisition which will allow it to ...
The Super Bowl aired a Hims & Hers commercial that is receiving backlash for its non-FDA approved weight loss drug. This drug ...
Stock futures rise as traders eye Fed minutes and tariffs. Tesla, Intel, and Buffett-backed Constellation lead pre-market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback